PTC Therapeutics | PTCT - 销售收入



金融业
股票价格
USD
资产
USD 2.87B
现金及等价物
USD 833.99M
销售成本
USD 39.61M
流动资产
USD 2.25B
流动负债
USD 923.6M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -0.03
股本和储备
USD -180.47M
销售毛利
USD 232.94M
债务利息支出
USD 2.87B
贷款资金
USD 286.94M
市值
USD 5.35B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -2.46M
销售收入
USD 273M
销售和管理费用
USD 73.89M
股票
USD 75.57M
贸易债权人
USD 25.48M
应收帐款人
USD 181.62M


销售 更改 日
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amgen USD 8.62B 1.28B 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Cytokinetics USD 19.35M 1.59M 2026-03
Daiichi Sankyo JPY 587B 28.89B 2026-03
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Gilead Sciences USD 7B 930M 2026-03
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
TG Therapeutics USD 194.8M 2.23M 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03
Xencor USD 4.51M 23.73M 2026-03